| New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes ... - MarketWatch (press release) |
|
|
MarketWatch (press release) Approximately one-third of the patients were undergoing dialysis therapy for end-stage renal disease at the time of entry, and the remaining patients were pre-dialysis patients with advanced CKD with a median estimated glomerular filtration rate (GFR, |